An ultra-brief anxiety prescreen. A score of 3 or higher warrants administration of the full GAD-7.
Publisher: Developed by Drs. Spitzer, Kroenke, Williams, and Löwe with an unrestricted educational grant from Pfizer Inc.
Citation: Kroenke, K., Spitzer, R.L., Williams, J.B.W., Monahan, P.O., & Löwe, B. (2007). Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Annals of Internal Medicine, 146(5), 317-325.